AtriCure, Inc. (ATRC)
48.62
+0.27
(+0.56%)
USD |
NASDAQ |
Sep 01, 12:17
AtriCure Total Long Term Debt (Quarterly) : 72.53M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 72.53M |
| March 31, 2026 | 73.22M |
| December 31, 2025 | 74.77M |
| September 30, 2025 | 81.25M |
| June 30, 2025 | 75.59M |
| March 31, 2025 | 75.79M |
| December 31, 2024 | 74.91M |
| September 30, 2024 | 75.57M |
| June 30, 2024 | 73.90M |
| March 31, 2024 | 73.91M |
| December 31, 2023 | 73.05M |
| September 30, 2023 | 73.07M |
| June 30, 2023 | 73.49M |
| March 31, 2023 | 73.90M |
| December 31, 2022 | 70.07M |
| September 30, 2022 | 73.75M |
| June 30, 2022 | 74.08M |
| March 31, 2022 | 74.47M |
| December 31, 2021 | 74.79M |
| September 30, 2021 | 69.14M |
| June 30, 2021 | 73.56M |
| March 31, 2021 | 61.11M |
| December 31, 2020 | 66.41M |
| September 30, 2020 | 73.23M |
| June 30, 2020 | 73.23M |
| Date | Value |
|---|---|
| March 31, 2020 | 74.62M |
| December 31, 2019 | 74.96M |
| September 30, 2019 | 74.93M |
| June 30, 2019 | 47.53M |
| March 31, 2019 | 46.72M |
| December 31, 2018 | 52.46M |
| September 30, 2018 | 52.45M |
| June 30, 2018 | 52.48M |
| March 31, 2018 | 52.51M |
| December 31, 2017 | 37.42M |
| September 30, 2017 | 38.69M |
| June 30, 2017 | 38.76M |
| March 31, 2017 | 38.83M |
| December 31, 2016 | 38.89M |
| September 30, 2016 | 38.94M |
| June 30, 2016 | 38.95M |
| March 31, 2016 | 14.05M |
| December 31, 2015 | 14.16M |
| September 30, 2015 | 0.068M |
| June 30, 2015 | 0.068M |
| March 31, 2015 | 0.079M |
| December 31, 2014 | 0.114M |
| September 30, 2014 | 2.596M |
| June 30, 2014 | 0.106M |
| March 31, 2014 | 0.107M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Boston Scientific Corp. | 12.62B |
| Abbott Laboratories | 32.61B |
| AngioDynamics, Inc. | 9.66M |
| Alphatec Holdings, Inc. | 597.42M |
| Baxter International, Inc. | 8.857B |